Injectable Calcium Hydroxylapatite for Correction of Nasal Bridge Deformities

Abstract

Background

Minimally invasive procedures for aesthetic surgery have become widely popular, and facial soft tissue augmentation is one of the most common procedures. Various kinds of fillers have been used, and recently the use of calcium hydroxylapatite was extended to cosmetic facial procedures. This article presents the authors’ experience with primary and secondary nasal bridge correction using calcium hydroxylapatite (Radiesse).

Methods

This preliminary prospective study investigated the use of commercially available calcium hydroxylapatite (Radiesse) for correction of nasal bridge deformities. Calcium hydroxylapatite was injected on the plane of the periosteum in a retrograde fashion using a linear, threading, fanning, or crosshatching technique. The patients were followed for several months, with the outcome and side effects assessed both subjectively and objectively.

Results

Patients showed a persistence of benefit up to 1 year during the follow-up period, with pleasing long-term results.

Conclusion

Calcium hydroxylapatite (Radiesse) is a useful injectable filler for correction of nasal bridge deformities. Further efficacy studies seem justified.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Busso M, Karlsberg PL (2006) Check augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse). Cosmet Dermatol 19:583

    Google Scholar 

  2. 2.

    Carruthers A, Liebeskind B, Carruthers J, Forster BB (2008) Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg 34(Suppl 1):S78–S84

    Google Scholar 

  3. 3.

    Felderman LI (2005) Radiesse for facial rejuvenation. Cosmet Dermatol 18:823

    Google Scholar 

  4. 4.

    Goldberg DJ (2006) Calcium hydroxylapatite: fillers in cosmetic dermatology. Informa UK Ltd, Abingdon, England

    Google Scholar 

  5. 5.

    Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL (2007) Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 120(Suppl):55S–66S

    Google Scholar 

  6. 6.

    Hubbard W (2002) BioForm implants: durability. Bioform, Inc, Franksville

  7. 7.

    Hubbard W (2003) BioForm implants: biocompatibility. Bioform, Inc, Franksville

    Google Scholar 

  8. 8.

    Jansen DA, Graivier MH (2006) Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft tissue augmentation. Plast Reconstr Surg 118(Suppl.):22S

    Google Scholar 

  9. 9.

    Jones JK (2006) Patient safety considerations regarding dermal filler injections. Plast Surg Nurs 26:156

    PubMed  Google Scholar 

  10. 10.

    Marmur ES, Phelps R, Goldberg DJ (2004) Clinical, histologic, and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 6:223

    PubMed  Article  Google Scholar 

  11. 11.

    Tzikas TL (2004) Evaluation of Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 6:234

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Horia R. Siclovan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Siclovan, H.R., Jomah, J.A. Injectable Calcium Hydroxylapatite for Correction of Nasal Bridge Deformities. Aesth Plast Surg 33, 544–548 (2009). https://doi.org/10.1007/s00266-008-9281-0

Download citation

Keywords

  • Calcium hydroxylapatite
  • Nasal bridge correction
  • Radiesse